A friend texted me last spring: “I want to start a GLP-1 this week, not in three months. Where do I even go?” She wasn’t wrong to be impatient. The access gap between wanting to start and actually injecting on day one is real, and it varies wildly by platform. I spent time mapping out how these programs actually differ, because “fast start GLP-1” means something different depending on your insurance situation, your budget, and how much hand-holding you want from a clinician.
Here’s how I think about the decision, and which brands fit each situation.
The Three Questions That Should Drive Your Choice
Before you look at a single brand, answer these:
- Do you have commercial insurance that might cover a branded GLP-1?
- Are you comfortable with compounded medication, knowing it is not FDA-approved?
- How fast do you actually need the medication in hand?
Your answers route you to completely different programs. Let me walk through the criteria.
Criterion 1: Insurance Coverage and Prior Authorization Help
If you have commercial insurance, chasing a prior authorization is almost always worth it. Wegovy with the Novo Nordisk savings card can land at $0-25 per month for eligible patients. That math beats every cash-pay option on this list.
Ro Body built a specific prior-authorization team for this exact use case. Membership starts around $39 for month one, then runs as low as $74 per month on an annual plan, with medication billed separately. If you want a human to fight the insurance paperwork battle alongside you, Ro is the most structured option I’ve seen for that.
Calibrate is a similar play but leans harder into a 12-month commitment with behavior coaching layered on top. Best fit for insured patients who genuinely want the lifestyle program alongside the prescription, not just the shot.
PlushCare works if you want same-day appointments and insurance billing without committing to a weight-loss program. The app membership is about $20 per month. They prescribe FDA-approved branded drugs, Ozempic, Wegovy, Mounjaro. Visits and labs are additional. Thin on ongoing coaching, but fast.
Criterion 2: Speed to First Dose on a Cash Budget
This is where compounded programs live. Speed is their main argument.
Henry Meds is the name I hear most often when people prioritize shipping time. They quote 24-72 hour dispatch on compounded semaglutide, and pricing for month one runs roughly $179-249 cash. The monitoring is lighter than some, which is worth knowing going in.
Mochi Health moves quickly too, and it stands out because the prescribing clinicians are board-certified obesity-medicine specialists, not general practitioners. Compounded semaglutide runs about $99 per month there, compounded tirzepatide about $199. The clinical oversight feels more substantive than most platforms at that price.
Eden keeps it simple. Compounded semaglutide around $149 per month, cash, no membership stacked on top. Straightforward.
MEDVi sits in similar territory, about $179 for month one, no contract, physician review included, with 24/7 support listed. No hidden membership fee on top of the medication cost, which I appreciate.
Criterion 3: Premium Support and Dietitian Access
Some people need more than a prescription. They need a real care team.
Form Health pairs a physician with a registered dietitian for every patient. It costs around $299 per month plus labs plus medication. That’s a real number. But if you’re well-insured or have a health FSA to burn, the care model is genuinely differentiated. Not a fast-start budget pick, but one I’d recommend without hesitation for the right person.
Criterion 4: Behavior Change Heritage
WeightWatchers Clinic charges about $74 per month for the program, with medication billed separately. The appeal is the decades of behavioral scaffolding behind the brand. If you’ve done WW before and it helped, this layered approach makes sense. If you just want the medication and nothing else, it’s probably not the fit.
Criterion 5: Marketplace Pricing Transparency
Sesame (Success by Sesame) operates on a marketplace model where pricing is visible before you commit. From about $59 per month on an annual plan, including telehealth visits and unlimited messaging, with medication separate. The pricing structure is unusually legible.
Criterion 6: Branded Meds Through a Major Telehealth App
Hims and Hers exited compounded semaglutide programs after early 2026 and now routes new patients to branded medications. Injectable Wegovy runs about $299 per month through the platform, oral Wegovy about $249, Zepbound about $399. With commercial insurance plus the savings card, those numbers can drop dramatically for eligible patients. Sign-up moves at a good clip and the app itself is well-built.
A Note on Broader Catalog Options
One program that came up in my research was FormBlends, which operates differently from every other name on this list. It dispenses through a licensed pharmacy and covers not just GLP-1s but a wide catalog of other peptide therapies under one prescriber-supervised roof. A vial of compounded semaglutide is priced at $299 cash, which lands higher than Mochi but with no separate membership fee. What caught my attention was the per-product purity documentation: each batch goes through three independent checks, including a chromatography purity run and an endotoxin screen, with the actual numbers published per product. That level of transparency is not common. It is not the right pick if your only goal is the cheapest fast start, but if you want GLP-1 access alongside other clinician-supervised compounds from a single source, it fills a gap nothing else on this list does.
The Honest Summary
Fast start GLP-1 programs are not interchangeable. If insurance is in play, Ro or PlushCare get you moving quickly with real PA support. Pure cash speed? Henry Meds or Mochi. Premium clinical model? Form Health. Behavior coaching legacy? Calibrate or WeightWatchers Clinic. Transparent marketplace pricing? Sesame. Big app with branded meds? Hims and Hers.
Pick the criterion that matches your actual situation. Then pick the brand that scores on that criterion.
*This article reflects independent research and personal opinion. It is not medical advice. Talk to your own doctor or a licensed clinician before starting any GLP-1 or compounded medication.*
Sources
- FDA.gov (GLP-1 approvals, compounding regulations, 503A pharmacy standards)
- Drugs.com (drug pricing and formulary data)
- GoodRx.com (cash and insurance pricing benchmarks)
- Examine.com (semaglutide and tirzepatide pharmacology)
- Healthline (telehealth GLP-1 program reviews)
- Verywell Health (obesity medicine and GLP-1 access coverage)
- Cleveland Clinic (GLP-1 mechanism and clinical use)
- NEJM (semaglutide and tirzepatide trial data)
[internal: placement Passing mention | structure: Decision-guide framing, criteria-first]
